190 related articles for article (PubMed ID: 23240751)
1. Improved IgG3 levels and reduced infection rate in a woman with CVID switched from intravenous to subcutaneous immunoglobulin therapy.
Shapiro RS
Immunotherapy; 2012 Dec; 4(12):1835-9. PubMed ID: 23240751
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of intravenous immunoglobulin treatment in children with common variable immunodeficiency.
Baris S; Ercan H; Cagan HH; Ozen A; Karakoc-Aydiner E; Ozdemir C; Bahceciler NN
J Investig Allergol Clin Immunol; 2011; 21(7):514-21. PubMed ID: 22312934
[TBL] [Abstract][Full Text] [Related]
3. Serum IgG subclass concentrations before and after administration of intravenous immunoglobulin in common variable immunodeficiency.
Ozawa T; Motoyoshi F; Kato Y; Kondo N; Orii T
J Clin Lab Immunol; 1992; 38(1):29-39. PubMed ID: 1343346
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of immunoglobulin levels and infection rate in patients with common variable immunodeficiency after immunoglobulin replacement therapy.
Salehzadeh M; Aghamohammadi A; Rezaei N
J Microbiol Immunol Infect; 2010 Feb; 43(1):11-7. PubMed ID: 20434118
[TBL] [Abstract][Full Text] [Related]
5. Immunoglobulin treatment in primary antibody deficiency.
Maarschalk-Ellerbroek LJ; Hoepelman IM; Ellerbroek PM
Int J Antimicrob Agents; 2011 May; 37(5):396-404. PubMed ID: 21276714
[TBL] [Abstract][Full Text] [Related]
6. Clinical and immunologic features of pediatric patients with common variable immunodeficiency and respiratory complications.
Aydogan M; Eifan AO; Gocmen I; Ozdemir C; Bahceciler NN; Barlan IB
J Investig Allergol Clin Immunol; 2008; 18(4):260-5. PubMed ID: 18714533
[TBL] [Abstract][Full Text] [Related]
7. Subcutaneous immunoglobulin therapy in an 11-year-old patient with common variable immunodeficiency and von Willebrand disease.
Arora R; Newton TC; Nelson MR
Ann Allergy Asthma Immunol; 2007 Oct; 99(4):367-70. PubMed ID: 17941286
[TBL] [Abstract][Full Text] [Related]
8. The Natural History of Untreated Primary Hypogammaglobulinemia in Adults: Implications for the Diagnosis and Treatment of Common Variable Immunodeficiency Disorders (CVID).
Ameratunga R; Ahn Y; Steele R; Woon ST
Front Immunol; 2019; 10():1541. PubMed ID: 31379811
[No Abstract] [Full Text] [Related]
9. Intravenous immunoglobulin replacement prevents severe and lower respiratory tract infections, but not upper respiratory tract and non-respiratory infections in common variable immune deficiency.
Favre O; Leimgruber A; Nicole A; Spertini F
Allergy; 2005 Mar; 60(3):385-90. PubMed ID: 15679727
[TBL] [Abstract][Full Text] [Related]
10. Novel variant of common variable immunodeficiency.
Conaway E
BMJ Case Rep; 2017 May; 2017():. PubMed ID: 28551598
[TBL] [Abstract][Full Text] [Related]
11. Intravenous immunoglobulin (IVIG) efficiency in women with common variable immunodeficiency (CVID) decreases significantly during pregnancy.
Egawa M; Kanegane H; Imai K; Morio T; Miyasaka N
J Matern Fetal Neonatal Med; 2019 Sep; 32(18):3092-3096. PubMed ID: 29614902
[TBL] [Abstract][Full Text] [Related]
12. Practical aspects of immunoglobulin replacement.
Ballow M
Ann Allergy Asthma Immunol; 2017 Oct; 119(4):299-303. PubMed ID: 28958372
[No Abstract] [Full Text] [Related]
13. Reconstitution of IgG Subclasses Following Immunoglobulin Administration in Adult Patients with Common Variable Immune Deficiency.
Reeder D; Gupta S
Int Arch Allergy Immunol; 2021; 182(3):243-253. PubMed ID: 33053553
[TBL] [Abstract][Full Text] [Related]
14. [Subcutaneous gammaglobulin in common variable immunodeficiency. First experience in Spain].
Maroto Hernando M; Soler Palacín P; Martin Nalda N; Oliveras Arenas M; Español Boren T; Figueras Nadal C
An Pediatr (Barc); 2009 Feb; 70(2):111-9. PubMed ID: 19217565
[TBL] [Abstract][Full Text] [Related]
15. Subcutaneous immunoglobulin replacement therapy for primary antibody deficiency: advancements into the 21st century.
Moore ML; Quinn JM
Ann Allergy Asthma Immunol; 2008 Aug; 101(2):114-21; quiz 122-3, 178. PubMed ID: 18727465
[TBL] [Abstract][Full Text] [Related]
16. Home therapy with subcutaneous immunoglobulins for patients with primary immunodeficiency diseases.
Haddad É; Barnes D; Kafal A
Transfus Apher Sci; 2012 Jun; 46(3):315-21. PubMed ID: 22503304
[TBL] [Abstract][Full Text] [Related]
17. Subcutaneous immunoglobulin: rapid push vs. infusion pump in pediatrics.
Shapiro RS
Pediatr Allergy Immunol; 2013 Feb; 24(1):49-53. PubMed ID: 23331529
[TBL] [Abstract][Full Text] [Related]
18. [Immunoglobulin therapy of primary humoral immunologic deficiencies].
Bordigoni P
Rev Prat; 2007 Oct; 57(15):1691-8. PubMed ID: 18080428
[TBL] [Abstract][Full Text] [Related]
19. Recurrent multi-organism keratoconjunctivitis manifesting as a first presentation of common variable immune deficiency (CVID).
Ooi KG; Joshua F; Broadfoot A
Ocul Immunol Inflamm; 2007; 15(5):403-5. PubMed ID: 17972226
[TBL] [Abstract][Full Text] [Related]
20. Improved quality of life, immunoglobulin G levels, and infection rates in patients with primary immunodeficiency diseases during self-treatment with subcutaneous immunoglobulin G.
Berger M; Murphy E; Riley P; Bergman GE;
South Med J; 2010 Sep; 103(9):856-63. PubMed ID: 20689467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
